U.S. FDA approves new breast cancer drug that could slow disease significantly
⚡ Quick Summary
Revtorpyk is intended to treat patients with advanced breast cancer whose tumors have low levels of a protein called HER2 and no mutation in a gene called PIK3CA.
🗞️ 1 sources covered this story
📰 Related Articles
Passport just a document to regulate departure of citizens from India: MEA
Times of India
‘I can’t keep losing everything’: Pierrefonds residents demand flooding solution
Global News CA
Norway firm to set up India’s first river kinetic energy demo plant in Arunachal
The Hindu
Dr. Mustafa Kamal, the Abdullah who rooted for J&K’s pre-1953 position, dies in Srinagar
The Hindu
Dallas se llena de vida con las aficiones de Francia y España, jugando por un boleto a la final
NBC News